{"transactions":[{"id":683749,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-18T21:21:16.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":3040,"price":23.23,"value":70619.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on August 12, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 511.471 shares of common stock acquired under the issuer's employee stock purchase plan in June 2026."}],"balance_after":216383.646,"source":{"system":"sec-edgar","filing":"0001628280-26-057759","document":"wk-form4_1787088074.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000162828026057759/wk-form4_1787088074.xml","form_type":"4"}},{"id":748210,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-05T21:57:08.000Z","date":"2026-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":4728,"price":22.32,"value":105528.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":218912.175,"source":{"system":"sec-edgar","filing":"0001628280-26-041331","document":"wk-form4_1780696625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000162828026041331/wk-form4_1780696625.xml","form_type":"4"}},{"id":833639,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-19T21:43:08.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":3261,"price":22.82,"value":74416.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on August 12, 2025."}],"balance_after":223640.175,"source":{"system":"sec-edgar","filing":"0001628280-26-019891","document":"wk-form4_1773956586.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000162828026019891/wk-form4_1773956586.xml","form_type":"4"}},{"id":905381,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-13T21:01:56.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":54546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on February 15, 2027, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":226901.175,"source":{"system":"sec-edgar","filing":"0001628280-26-008075","document":"wk-form4_1771016513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000162828026008075/wk-form4_1771016513.xml","form_type":"4"}},{"id":922179,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-03T23:23:53.000Z","date":"2026-01-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":6168,"price":20.54,"value":126690.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":172355.175,"source":{"system":"sec-edgar","filing":"0001628280-26-005155","document":"wk-form4_1770161031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000162828026005155/wk-form4_1770161031.xml","form_type":"4"}},{"id":947116,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-06T22:30:54.000Z","date":"2026-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":381,"price":24.46,"value":9319.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 537.166 shares of common stock acquired under the issuer's employee stock purchase plan in December 2025."}],"balance_after":178523.175,"source":{"system":"sec-edgar","filing":"0001628280-26-000968","document":"wk-form4_1767738651.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000162828026000968/wk-form4_1767738651.xml","form_type":"4"}},{"id":994094,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-19T21:32:02.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":3960,"price":24.09,"value":95396.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":178367.009,"source":{"system":"sec-edgar","filing":"0001628280-25-053205","document":"wk-form4_1763587920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000162828025053205/wk-form4_1763587920.xml","form_type":"4"}},{"id":1076411,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-04T20:31:02.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":315,"price":22.07,"value":6952.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 682.498 shares of common stock acquired under the issuer's employee stock purchase plan in June 2025."}],"balance_after":182327.009,"source":{"system":"sec-edgar","filing":"0001396814-25-000095","document":"wk-form4_1754339458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681425000095/wk-form4_1754339458.xml","form_type":"4"}},{"id":1121524,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-06-05T21:37:39.000Z","date":"2025-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":5084,"price":26.4,"value":134217.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":181959.511,"source":{"system":"sec-edgar","filing":"0001396814-25-000067","document":"wk-form4_1749159413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681425000067/wk-form4_1749159413.xml","form_type":"4"}},{"id":1285205,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-04T23:26:04.000Z","date":"2025-02-01","kind":"grant","planned":false,"acquired":true,"shares":93600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on February 1, 2026, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":187043.511,"source":{"system":"sec-edgar","filing":"0001396814-25-000033","document":"wk-form4_1738711558.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681425000033/wk-form4_1738711558.xml","form_type":"4"}},{"id":1311046,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-06T23:23:10.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":879,"price":18.4,"value":16173.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":93443.511,"source":{"system":"sec-edgar","filing":"0001396814-25-000007","document":"wk-form4_1736205784.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681425000007/wk-form4_1736205784.xml","form_type":"4"}},{"id":1311045,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-06T23:23:10.000Z","date":"2025-01-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":371,"price":18.33,"value":6800.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 386.765 shares of common stock acquired under the issuer's employee stock purchase plan in December 2024."}],"balance_after":94322.511,"source":{"system":"sec-edgar","filing":"0001396814-25-000007","document":"wk-form4_1736205784.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681425000007/wk-form4_1736205784.xml","form_type":"4"}},{"id":1443107,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-08-02T22:00:57.000Z","date":"2024-08-02","kind":"sale","planned":true,"acquired":false,"shares":945,"price":20.05,"value":18947.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":94306.746,"source":{"system":"sec-edgar","filing":"0001396814-24-000100","document":"wk-form4_1722636050.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681424000100/wk-form4_1722636050.xml","form_type":"4"}},{"id":1443106,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-08-02T22:00:57.000Z","date":"2024-08-01","kind":"tax_withholding","planned":true,"acquired":false,"shares":305,"price":20.75,"value":6328.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":95251.746,"source":{"system":"sec-edgar","filing":"0001396814-24-000100","document":"wk-form4_1722636050.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681424000100/wk-form4_1722636050.xml","form_type":"4"}},{"id":1460394,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-07-03T22:52:22.000Z","date":"2024-07-02","kind":"sale","planned":true,"acquired":false,"shares":2836,"price":28.25,"value":80117.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":95556.746,"source":{"system":"sec-edgar","filing":"0001396814-24-000088","document":"wk-form4_1720047136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681424000088/wk-form4_1720047136.xml","form_type":"4"}},{"id":1460393,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-07-03T22:52:22.000Z","date":"2024-07-01","kind":"tax_withholding","planned":true,"acquired":false,"shares":914,"price":28.46,"value":26012.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":98392.746,"source":{"system":"sec-edgar","filing":"0001396814-24-000088","document":"wk-form4_1720047136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681424000088/wk-form4_1720047136.xml","form_type":"4"}},{"id":1460392,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-07-03T22:52:22.000Z","date":"2024-06-28","kind":"grant","planned":true,"acquired":true,"shares":437.271,"price":24.319,"value":10633.993449,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock acquired under the issuer's employee stock purchase plan in June 2024."}],"balance_after":99306.746,"source":{"system":"sec-edgar","filing":"0001396814-24-000088","document":"wk-form4_1720047136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681424000088/wk-form4_1720047136.xml","form_type":"4"}},{"id":1480903,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-06-13T22:15:03.000Z","date":"2024-06-12","kind":"grant","planned":true,"acquired":true,"shares":54300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2025, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":98869.475,"source":{"system":"sec-edgar","filing":"0001396814-24-000084","document":"wk-form4_1718316890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681424000084/wk-form4_1718316890.xml","form_type":"4"}},{"id":1480902,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-06-13T22:15:03.000Z","date":"2024-06-11","kind":"sale","planned":true,"acquired":false,"shares":5012,"price":28.57,"value":143192.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":44569.475,"source":{"system":"sec-edgar","filing":"0001396814-24-000084","document":"wk-form4_1718316890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681424000084/wk-form4_1718316890.xml","form_type":"4"}},{"id":1490330,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-06-05T21:09:06.000Z","date":"2024-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1615,"price":30.89,"value":49887.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":49581.475,"source":{"system":"sec-edgar","filing":"0001396814-24-000051","document":"wk-form4_1717621737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681424000051/wk-form4_1717621737.xml","form_type":"4"}},{"id":1688321,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T22:24:39.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":32.07,"expiration_date":"2034-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001396814-24-000013","document":"wk-form4_1704407065.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681424000013/wk-form4_1704407065.xml","form_type":"4"}},{"id":1688320,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-04T22:24:39.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on January 2, 2025, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 311.535 shares of common stock acquired under the issuer's employee stock purchase plan in December 2023."}],"balance_after":51196.475,"source":{"system":"sec-edgar","filing":"0001396814-24-000013","document":"wk-form4_1704407065.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000139681424000013/wk-form4_1704407065.xml","form_type":"4"}},{"id":1864153,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Common Stock","published_at":"2023-06-08T01:32:14.000Z","date":"2023-06-07","kind":"sale","planned":false,"acquired":false,"shares":490,"price":37.865,"value":18553.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":36323,"source":{"system":"sec-edgar","filing":"0001209191-23-035263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000120919123035263/doc4.xml","form_type":"4"}},{"id":1864152,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Common Stock","published_at":"2023-06-08T01:32:14.000Z","date":"2023-06-06","kind":"sale","planned":false,"acquired":false,"shares":471,"price":38.991,"value":18364.761,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 205 shares of common stock acquired under the issuer's employee stock purchase plan in December 2022."}],"balance_after":36813,"source":{"system":"sec-edgar","filing":"0001209191-23-035263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000120919123035263/doc4.xml","form_type":"4"}},{"id":2193486,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Common Stock","published_at":"2022-08-05T20:04:49.000Z","date":"2022-08-03","kind":"sale","acquired":false,"shares":308,"price":55.7,"value":17155.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":37079,"source":{"system":"sec-edgar","filing":"0001209191-22-044554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000120919122044554/doc4.xml","form_type":"4"}},{"id":2210858,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Common Stock","published_at":"2022-07-07T23:04:19.000Z","date":"2022-07-05","kind":"sale","acquired":false,"shares":924,"price":57.188,"value":52841.712,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 214 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022."}],"balance_after":37387,"source":{"system":"sec-edgar","filing":"0001209191-22-041521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000120919122041521/doc4.xml","form_type":"4"}},{"id":2239249,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-08T23:45:25.000Z","date":"2022-06-08","kind":"sale","acquired":true,"shares":24800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":24800,"derivative":{"exercise_price":59.39,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":24800},"source":{"system":"sec-edgar","filing":"0001209191-22-035232","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000120919122035232/doc4.xml","form_type":"4"}},{"id":2239248,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Common Stock","published_at":"2022-06-08T23:45:25.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":9900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":38097,"source":{"system":"sec-edgar","filing":"0001209191-22-035232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000120919122035232/doc4.xml","form_type":"4"}},{"id":2239247,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Common Stock","published_at":"2022-06-08T23:45:25.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":362,"price":61.374,"value":22217.388,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":28197,"source":{"system":"sec-edgar","filing":"0001209191-22-035232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000120919122035232/doc4.xml","form_type":"4"}},{"id":2256921,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-25T20:16:23.000Z","date":"2022-05-23","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":35500,"derivative":{"exercise_price":52.37,"expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-22-031854","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000120919122031854/doc4.xml","form_type":"4"}},{"id":2256920,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Common Stock","published_at":"2022-05-25T20:16:23.000Z","date":"2022-05-23","kind":"exercise","acquired":true,"shares":2000,"price":52.37,"value":104740.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 209 shares of common stock acquired under the issuer's employee stock purchase plan in December 2021."}],"balance_after":28559,"source":{"system":"sec-edgar","filing":"0001209191-22-031854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000120919122031854/doc4.xml","form_type":"4"}},{"id":2613240,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T20:29:50.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the option shares on July 20, 2022, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":60.79,"expiration_date":"2031-07-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-049940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000120919121049940/doc4.xml","form_type":"4"}},{"id":2613239,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":22309,"kind":"person","name":"SLONIN JONATHAN","position":1,"cik":"0001875723","reported_name":"SLONIN JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Common Stock","published_at":"2021-08-05T20:29:50.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on August 1, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":26350,"source":{"system":"sec-edgar","filing":"0001209191-21-049940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875723/000120919121049940/doc4.xml","form_type":"4"}}]}